The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Kishore M. Gadde

Obesity Clinical Trials Programme

Duke University Medical Center

Durham

NC 27710

USA

[email]@mc.duke.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Obesity Clinical Trials Programme, Duke University Medical Center, Durham, NC 27710, USA. 2001 - 2011
  • Duke University Medical Centre, Durham, NC 27710, USA. 2007

References

  1. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Gadde, K.M., Allison, D.B., Ryan, D.H., Peterson, C.A., Troupin, B., Schwiers, M.L., Day, W.W. Lancet (2011) [Pubmed]
  2. Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. Gadde, K.M., Yonish, G.M., Foust, M.S., Wagner, H.R. J. Clin. Psychiatry (2007) [Pubmed]
  3. Escitalopram treatment of trichotillomania. Gadde, K.M., Ryan Wagner, H., Connor, K.M., Foust, M.S. Int. Clin. Psychopharmacol (2007) [Pubmed]
  4. Bupropion for weight reduction. Gadde, K.M., Xiong, G.L. Expert. Rev. Neurother (2007) [Pubmed]
  5. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial. Gadde, K.M., Yonish, G.M., Wagner, H.R., Foust, M.S., Allison, D.B. Int. J. Obes. (Lond) (2006) [Pubmed]
  6. Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial. Gadde, K.M., Zhang, W., Foust, M.S. J. Clin. Psychopharmacol (2006) [Pubmed]
  7. Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks. Gadde, K.M., Allison, D.B. Circulation (2006) [Pubmed]
  8. Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reduction. Gadde, K.M. Curr. Drug. Targets. Cardiovasc. Haematol. Disord (2005) [Pubmed]
  9. Zonisamide for weight loss in obese adults: a randomized controlled trial. Gadde, K.M., Franciscy, D.M., Wagner, H.R., Krishnan, K.R. JAMA (2003) [Pubmed]
  10. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Gadde, K.M., Parker, C.B., Maner, L.G., Wagner, H.R., Logue, E.J., Drezner, M.K., Krishnan, K.R. Obes. Res. (2001) [Pubmed]
 
WikiGenes - Universities